To study whether blocking the CCL21/CCR7 axis can inhibit the lymphatic metastasis of melanoma after PTX treatment, CCR7 mAb was applied to block the CCL21/CCR7 signalling pathway in vivo. This evidence concerns the gene CCR7 and melanoma.